A next-generation form of chemotherapy from AstraZeneca and Daiichi Sankyo has won Food and Drug Administration authorization for a form of breast cancer, the first U.S. approval for a drug for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback